Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic models
CPT: Pharmacometrics & Systems Pharmacology · 2024
DOI: 10.1002/psp4.13256 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2024. Verfasst von Abdulkarim Najjar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beiersdorf AG, Hamburg, Germany. Hauptthemen laut MEDLINE: Models, Biological, Software, Pharmacokinetics. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Sensitivity analyses are important components of physiologically based pharmacokinetic (PBPK) model development and are required by regulatory agencies for PBPK submissions. They assess the impact of parametric uncertainty and variability on model estimates, aid model optimization by identifying parameters requiring calibration, and enable the testing of assumptions within PBPK models. One‐at‐a‐time (OAT) sensitivity analyses quantify the impact on a model output in response to changes in a single parameter while holding others fixed. Global sensitivity analysis (GSA) methods provide more comprehensive assessments by accounting for changes in all uncertain or variable parameters, though at a higher computational cost. This tutorial article presents a software package for conducting both OAT and GSA of PBPK models built in the Open Systems Pharmacology (OSP) Suite. The tool is accessible through either an R script or a graphical user interface, and the outputs consist of sensitivity metrics of pharmacokinetic (PK) parameters, such as C max and AUC, evaluated with respect to model input parameters. Results are formatted according to regulatory standards. The OAT analysis methods comprise two‐way local sensitivity analyses and probabilistic uncertainty analyses, whereas the GSA methods include the Morris, Sobol, and EFAST methods. These analyses can be conducted on single PBPK models or pairs of models for the evaluation of the sensitivity of PK parameter ratios in drug–drug interaction studies. The practical application of the package is demonstrated through three illustrative case studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Beiersdorf AG, Hamburg, Germany.
- School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada.
- Systems In Silico Ltd., Waterloo, Ontario, Canada.
ORCID-Profile: Abdulkarim Najjar, Abdullah Hamadeh
Zitieren
APA
Najjar, A., Hamadeh, A., Krause, S., Schepky, A., & Edginton, A. (2024). Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic models. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13256
Vancouver
Najjar A, Hamadeh A, Krause S, Schepky A, Edginton A. Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic models. CPT: Pharmacometrics & Systems Pharmacology. 2024. doi:10.1002/psp4.13256
BibTeX
@article{Najjar2024,
author = {Najjar, Abdulkarim and Hamadeh, Abdullah and Krause, Sophia and Schepky, Andreas and Edginton, Andrea},
title = {Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic models},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2024},
doi = {10.1002/psp4.13256}
}
EUVIMED